Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Tetragon Biosciences Ltd

Clinical trials sponsored by Tetragon Biosciences Ltd, explained in plain language.

Upcoming readouts

Trials from this sponsor expected to report results within the next 12 months.

New pill takes on aggressive brain tumors in early trial Results expected Jun 2027 (estimated)

Browse trials soon ready across all sponsors →

Trials to join now! 1

New pill takes on aggressive brain tumors in early trial

Disease control Recruiting now

This early-stage trial tests an oral drug called GLIX1 in 30 adults with recurrent or progressive high-grade glioma, a fast-growing brain cancer. The study aims to find the safest dose and check for any signs of tumor control. Participants take the drug daily until their disease …

Phase 1 • Sponsor: Tetragon Biosciences Ltd • Aim: Disease control

Last updated Aug 01, 2026 00:00 UTC